This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Rexahn Pharmaceuticals, Inc.. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: The Innovative Path of Godefridus J Peters in Cancer Treatment
Introduction: Godefridus J Peters, hailing from Amsterdam, NL, is a renowned inventor with two patents under his belt. His pioneering work in cancer treatment has garnered widespread recognition in the scientific community.
Latest Patents: Peters's latest patents include "Fluorocyclopentenylcytosine methods of use" which revolutionizes the treatment of cancer by administering compounds of formula (I) to alleviate symptoms and enhance patient outcomes.
Career Highlights: Godefridus J Peters is a key figure at Rexahn Pharmaceuticals, Inc., a leading pharmaceutical company at the forefront of oncology research and drug development. His groundbreaking discoveries have significantly advanced the field of cancer therapeutics.
Collaborations: Peters collaborates closely with esteemed colleagues such as Young Bok Lee and Deog Joong Kim, who share his vision for innovative cancer treatments. Together, they form a dynamic team driving cutting-edge research and development in the fight against cancer.
Conclusion: Godefridus J Peters's relentless dedication to innovation in cancer treatment has cemented his legacy as a trailblazing inventor. His contributions to the field continue to inspire future generations of inventors and researchers in the quest for improved patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile